A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant

• Status: COMPLETED
• Trial end date: 2025-04-04

Summary

This study medicine NNC0487-0111 to improve the treatment options for people living with overweight and obesity or with type 2 diabetes. The purpose of the study is to investigate if NNC0487-0111 affects how effective birth control pills are. Participants will take 1-tablet once daily. The study medicine will taken orally for 18 weeks and then study medicine will be injected with a thin needle in a skin fold in the abdomen for 9 weeks.The study will last for about 35 weeks.

• Phase: PHASE1

Details

• Lead Sponsor: Novo Nordisk A/S
• Treatments: Acetaminophen; Contraceptive Agents; Ethinyl Estradiol; Levonorgestrel